vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Third Coast Bancshares, Inc. (TCBX). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $57.7M, roughly 1.4× Third Coast Bancshares, Inc.). Third Coast Bancshares, Inc. runs the higher net margin — 28.4% vs -38.1%, a 66.4% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 17.5%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Third Coast Bancshares, Inc. is a regional financial holding company headquartered in the U.S. Gulf Coast region. It provides a full suite of commercial and retail banking services including deposit products, business and consumer loans, mortgage services, and wealth management solutions, serving local small and medium-sized enterprises, individual consumers, and community clients across Texas and surrounding areas.
PRCT vs TCBX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $83.1M | $57.7M |
| Net Profit | $-31.6M | $16.4M |
| Gross Margin | 64.9% | — |
| Operating Margin | -4.1% | — |
| Net Margin | -38.1% | 28.4% |
| Revenue YoY | 20.2% | — |
| Net Profit YoY | -27.9% | 20.5% |
| EPS (diluted) | $-0.56 | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $83.1M | $57.7M | ||
| Q4 25 | $76.4M | $56.5M | ||
| Q3 25 | $83.3M | $54.5M | ||
| Q2 25 | $79.2M | $52.0M | ||
| Q1 25 | $69.2M | $45.9M | ||
| Q4 24 | $68.2M | $46.3M | ||
| Q3 24 | $58.4M | $42.9M | ||
| Q2 24 | $53.4M | $41.7M |
| Q1 26 | $-31.6M | $16.4M | ||
| Q4 25 | $-29.8M | $17.9M | ||
| Q3 25 | $-21.4M | $18.1M | ||
| Q2 25 | $-19.6M | $16.7M | ||
| Q1 25 | $-24.7M | $13.6M | ||
| Q4 24 | $-18.9M | $13.7M | ||
| Q3 24 | $-21.0M | $12.8M | ||
| Q2 24 | $-25.6M | $10.8M |
| Q1 26 | 64.9% | — | ||
| Q4 25 | 60.6% | — | ||
| Q3 25 | 64.8% | — | ||
| Q2 25 | 65.4% | — | ||
| Q1 25 | 63.9% | — | ||
| Q4 24 | 64.0% | — | ||
| Q3 24 | 63.2% | — | ||
| Q2 24 | 59.0% | — |
| Q1 26 | -4.1% | — | ||
| Q4 25 | -40.6% | 38.1% | ||
| Q3 25 | -27.8% | 41.9% | ||
| Q2 25 | -28.0% | 40.5% | ||
| Q1 25 | -39.7% | 37.8% | ||
| Q4 24 | -28.9% | 38.7% | ||
| Q3 24 | -38.4% | 37.9% | ||
| Q2 24 | -50.3% | 34.1% |
| Q1 26 | -38.1% | 28.4% | ||
| Q4 25 | -39.1% | 31.7% | ||
| Q3 25 | -25.7% | 33.1% | ||
| Q2 25 | -24.7% | 32.2% | ||
| Q1 25 | -35.8% | 29.6% | ||
| Q4 24 | -27.6% | 29.7% | ||
| Q3 24 | -35.9% | 29.8% | ||
| Q2 24 | -48.0% | 25.9% |
| Q1 26 | $-0.56 | $0.88 | ||
| Q4 25 | $-0.54 | $1.02 | ||
| Q3 25 | $-0.38 | $1.03 | ||
| Q2 25 | $-0.35 | $0.96 | ||
| Q1 25 | $-0.45 | $0.78 | ||
| Q4 24 | $-0.34 | $0.80 | ||
| Q3 24 | $-0.40 | $0.74 | ||
| Q2 24 | $-0.50 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.6M | — |
| Total DebtLower is stronger | $51.7M | — |
| Stockholders' EquityBook value | $347.7M | $650.5M |
| Total Assets | $487.1M | $6.6B |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.6M | — | ||
| Q4 25 | $286.5M | $175.2M | ||
| Q3 25 | $294.3M | $116.4M | ||
| Q2 25 | $302.7M | $113.1M | ||
| Q1 25 | $316.2M | $219.0M | ||
| Q4 24 | $333.7M | $371.2M | ||
| Q3 24 | $196.8M | $258.2M | ||
| Q2 24 | $214.1M | $241.8M |
| Q1 26 | $51.7M | — | ||
| Q4 25 | $51.6M | — | ||
| Q3 25 | $51.6M | — | ||
| Q2 25 | $51.5M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | $51.4M | — | ||
| Q2 24 | $51.4M | — |
| Q1 26 | $347.7M | $650.5M | ||
| Q4 25 | $365.9M | $531.0M | ||
| Q3 25 | $380.3M | $513.8M | ||
| Q2 25 | $385.8M | $496.1M | ||
| Q1 25 | $389.2M | $479.8M | ||
| Q4 24 | $402.2M | $460.7M | ||
| Q3 24 | $241.2M | $450.5M | ||
| Q2 24 | $251.8M | $435.0M |
| Q1 26 | $487.1M | $6.6B | ||
| Q4 25 | $508.1M | $5.3B | ||
| Q3 25 | $511.5M | $5.1B | ||
| Q2 25 | $513.1M | $4.9B | ||
| Q1 25 | $519.4M | $4.9B | ||
| Q4 24 | $534.0M | $4.9B | ||
| Q3 24 | $374.1M | $4.6B | ||
| Q2 24 | $374.4M | $4.5B |
| Q1 26 | 0.15× | — | ||
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
TCBX
| Net Interest Income | $53.6M | 93% |
| Noninterest Income | $4.0M | 7% |